Biomarin Pharmaceutical (BMRN) Cash & Equivalents (2009 - 2026)
Biomarin Pharmaceutical (BMRN) recorded Cash & Equivalents of $874.01 million in Q2 2026, down 28.0% from $1.21 billion a year earlier and down 60.7% from the prior quarter.
Powered by 
Analysis
Biomarin Pharmaceutical (BMRN) Cash & Equivalents (2009 - 2026) Analysis & Trends
At the end of FY2025, Biomarin Pharmaceutical reported Cash & Equivalents of $1.31 billion, up 39.1% from FY2024.
- Annual Cash & Equivalents has increased for four straight years, with a five-year compound annual growth rate of 15.1% (FY2020 to FY2025).
- Across earlier years, Cash & Equivalents came in at $942.84 million in FY2024 (+24.9%), $755.13 million in FY2023 (+4.2%), $724.53 million in FY2022 (+23.4%) and $587.28 million in FY2021 (-9.5%).
- The Q2 2026 figure is the lowest quarterly Cash & Equivalents since Q3 2024.
- On a year-over-year basis, Cash & Equivalents rose in six of the last eight quarters, with growth averaging 35.5%.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 111.9% in Q1 2026, against a decline of 39.2% in Q3 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at $2.22 billion (Q1 2026), $1.31 billion (Q4 2025) and $1.25 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Biomarin Pharmaceutical | 11.07 Bn | 4.93 Bn | 786.91 Mn | 874.01 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 874.01 Mn |
| Mar 31, 2026 | 2.22 Bn |
| Dec 31, 2025 | 1.31 Bn |
| Sep 30, 2025 | 1.25 Bn |
| Jun 30, 2025 | 1.21 Bn |
| Mar 31, 2025 | 1.05 Bn |
| Dec 31, 2024 | 942.84 Mn |
| Sep 30, 2024 | 675.45 Mn |
| Jun 30, 2024 | 972.15 Mn |
| Mar 31, 2024 | 747.00 Mn |
| Dec 31, 2023 | 755.13 Mn |
| Sep 30, 2023 | 785.41 Mn |
| Jun 30, 2023 | 694.38 Mn |
| Mar 31, 2023 | 580.07 Mn |
| Dec 31, 2022 | 724.53 Mn |
| Sep 30, 2022 | 761.52 Mn |
| Jun 30, 2022 | 619.80 Mn |
| Mar 31, 2022 | 605.44 Mn |
| Dec 31, 2021 | 587.28 Mn |
| Sep 30, 2021 | 617.14 Mn |
API Access
Biomarin Pharmaceutical Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=BMRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "BMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=BMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();